3Nybo M, Nielsen L B, Nielsen S J, et 81. Discordant expression of pro B type and pro C type natriuretie pep tide in newborn infants of mothers with type 1 diabet. Regul Pept, 2007,141 (13):135-139.
4Beer S, Golay S, Bardy D, et al. Increased plasma levels of N-terminal brain natriuretie peptide (NTpreBNP) in type 2 diabetic patients with vascular complications.Diabetes Metab, 2005, 31(6): 567-573.
6Yufu K, Takahashi N, Nakagawa M, et al. Brain natriuretic peptide and cardiac autonomic function in type 2 diabetic patients. Diabetes Res Clin Pract, 2006,72(1):12 -19.
3[24]BUCKLEY MG,JENKINS GH,MITCHELL AG,et al.Circulating C-type natriuretic peptide is increased in orthotopic cardiac transplant recipients and associated with cardiac allograft vasculopathy[J].Clin Sci (Loud),2000,99 (5):467.
4[25]HAN B,HASIN Y.Cardiovascular effects of natriuretic peptides and their interrelation with endothelin-1[J].Cardiovasc Drugs ther,2003,17 (1):41.
5[1]Yoshimura M,Yasue H,Ogawa H.Pathophysiological significance and clinical application of ANP and BNP in patients with heart failure[J].Can J Physiol Pharmacol,2001,79:730.
6[2]Ogawa Y,Tamura N,Chmho H,et al.Brain natriumie peptide appears to act locally as an antifibrolJe factor in the heart[J].Can J Physiol Pharmacol,2001,79(8):723.
7[3]Tokola H,Hautala N,Marttila M,et al.Mechancial load in duced alterations in B-type natriuretic peptide gene expression[J].Can J Physiol Pharmacol,2001,79 (8):646.
9[5]Selvais PL,Donckier J E.Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure:influences of left ventricular dysfunction and coronary artery disease on cardiac hormonal activation[J].Eur J Clin Inves-t,1998,28(8):636.
10[6]Okawa H,Horimoto H.Preischemic infusion of alpha2human atrial natriuretic peptide elicits myoprotection through a nitric oxide dependent mechanism[J].J Cardiol,2002,39(6):299.
